TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

28.60$ -0.3% vs. previous close Closing price · As of: Oct 30, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Zymeworks Inc. (ZYME) with date, type and a link to the original document.

Filings ZYME
Date Type Filing Original
10/23/2026 Current report (8-K) Zymeworks Inc. (ZYME): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
10/09/2026 Insider sale notice Form 144 filed with the SEC View document ↗
09/23/2026 Current report (8-K) Zymeworks Inc. (ZYME): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
08/25/2026 Current report (8-K) Zymeworks Inc. (ZYME): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View report ↗
08/06/2026 Current report (8-K) Zymeworks Inc. (ZYME): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?